Fudan University Cancer Hospital

Shanghai 200433

0 studies enrolling now · 4 studies all time

What they study most

HER2-Positive Primary Breast Cancer, Head And Neck Cancer, Head and Neck Cancer, Non-muscle Invasive Bladder Cancer, Residual Invasive Breast Cancer

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia — Running, not enrolling
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia — Completed